Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Greeve

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Therapeutische Umschau. Revue Therapeutique|October 21, 2004
[Uric acid and multiple sclerosis]H P Mattle, C Lienert, I Greeve
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2008
Atorvastatin decreases high-sensitivity C-reactive protein in multiple sclerosisJ Sellner, I Greeve, H P Mattle
Clinical and Experimental Immunology|March 18, 2008
Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosisJ Sellner, I Greeve, O Findling, et al.
Acta Neurologica Scandinavica|September 11, 2007
Anti-myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohortI Greeve, J Sellner, T Lauterburg, et al.
European Journal of Neurology|March 4, 2008
Acute partial transverse myelitis: risk factors for conversion to multiple sclerosisJ Sellner, N Lüthi, R Bühler, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 29, 2000
The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stressI Greeve, I Hermans-Borgmeyer, C Brellinger, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Therapeutische Umschau. Revue Therapeutique|October 21, 2004
[Uric acid and multiple sclerosis]H P Mattle, C Lienert, I Greeve
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 25, 2008
Atorvastatin decreases high-sensitivity C-reactive protein in multiple sclerosisJ Sellner, I Greeve, H P Mattle
Clinical and Experimental Immunology|March 18, 2008
Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosisJ Sellner, I Greeve, O Findling, et al.
Acta Neurologica Scandinavica|September 11, 2007
Anti-myelin antibodies in clinically isolated syndrome indicate the risk of multiple sclerosis in a Swiss cohortI Greeve, J Sellner, T Lauterburg, et al.
European Journal of Neurology|March 4, 2008
Acute partial transverse myelitis: risk factors for conversion to multiple sclerosisJ Sellner, N Lüthi, R Bühler, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 29, 2000
The human DIMINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stressI Greeve, I Hermans-Borgmeyer, C Brellinger, et al.
Pageof 1